跳至主要内容
临床试验/EUCTR2012-004518-32-AT
EUCTR2012-004518-32-AT进行中(未招募)1 期

ITIC2 Trial - Topical Imiquimod versus Conization to Treat Cervical Intraepithelial Neoplasia: Randomised Controlled, Non-inferiority Trial

Medizinische Universität Wien0 个研究点目标入组 500 人开始时间: 2013年1月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1)Women aged =18 years diagnosed with histologically verified CIN 3 and women aged = 30 years diagnosed with CIN 2
  • 2)Satisfactory colposcopy
  • 3)Signed informed consent
  • 4)Negative pregnancy test
  • 5)Appropriate contraception method for fertile women during active study period
  • 6)Adequate compliance
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 500
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1)Adenocarcinoma in situ
  • 2)History of previous conization
  • 3)Malignant disease at the time of inclusion
  • 4)Coploscopy suspicious for invasive disease
  • 5)Pregnancy and lactation period
  • 6)Known allergy or intolerance to IMQ
  • 7)Contraindications to conization or IMQ
  • 8)Symptoms of a clinical relevant disease
  • 9)Known HIV infection
  • 10)Evidence of a clinically significant immunodeficiency
  • 11)Participation in another experimental, interventional, protocol

研究者

相似试验